Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.28
+0.22 (1.99%)
At close: Jul 28, 2026, 4:00 PM EDT
11.45
+0.17 (1.51%)
After-hours: Jul 28, 2026, 4:10 PM EDT

Vicore Pharma Holding AB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3223,1711,9761,5401,280971
Market Cap Growth
47.95%60.51%28.34%20.27%31.77%-47.10%
Enterprise Value
212.423,0451,8711,4921,255930.44
Last Close Price
11.2811.268.4213.7817.4213.54
PS Ratio
868.127666.26199.93---
PB Ratio
3.0926.7119.3634.1146.1722.94
P/TBV Ratio
2.862.471.022.945.692.99
EV/Sales Ratio
573.177360.59189.36---
Net Debt / Equity Ratio
-1.07-1.06-1.02-1.06-0.90-0.97
Net Debt / EBITDA Ratio
2.192.586.021.520.901.28
Net Debt / FCF Ratio
2.603.117.011.930.871.40
Asset Turnover
0.000.000.13000
Quick Ratio
12.579.9717.8211.865.695.67
Current Ratio
12.6910.2818.2012.105.815.75
Return on Equity (ROE)
-45.49%-42.92%-21.28%-83.53%-85.79%-77.35%
Return on Assets (ROA)
-42.23%-37.48%-22.90%-76.83%-73.58%-65.29%
Return on Invested Capital (ROIC)
-----1482.23%-2488.73%
Return on Capital Employed (ROCE)
-46.32%-40.57%-24.48%-85.91%-85.88%-76.49%
Buyback Yield / Dilution
-50.17%-75.30%-41.72%-33.71%-3.64%-28.44%
Total Shareholder Return
-50.17%-75.30%-41.72%-33.71%-3.64%-28.44%